Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
NCT07808151Phase 2Recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 6
01
Overview
A Phase 2 trial of porustobart in colon cancer. Started Sep 2026; status: recruiting.
02
Drugs
porustobart
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT07808151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808151.